Bernard D. King

"Myxomatous" mitral valves: collagen dissolution as the primary defect.

Bernard D. King, M. A. Clark, Nobuhisa Baba et al. · Circulation · 1982 · 102 citations · Full text

Collagen Dissolution, Surgical Pathology, Histopathology +6

Increased HDL Cholesterol and ApoA-I in Humans and Mice Treated With a Novel SR-BI Inhibitor

David Masson, Masahiro Koseki, Minako Ishibashi et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 80 citations · Full text

58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION

Hendrik W. Reesink, H.L.A. Janssen, Stefan Zeuzem et al. · Journal of Hepatology · 2012 · 61 citations

Placebo-controlled Safety, Viral Hepatitis, Immunodeficiencies +8

Absence of hypertension despite chronic marked elevations in plasma norepinephrine in conscious dogs.

Bernard D. King, D. W. Sack, Maryanne R. Kichuk et al. · Hypertension · 1987 · 43 citations

Hypertension, Chronic Marked Elevations, Chronic Catecholamine Infusion +21

Clinical Use of Oral Verapamil in Chronic and Paroxysmal Atrial Fibrillation

Eric H. Stern, Roberta Pitchon, Bernard D. King et al. · CHEST Journal · 1982 · 28 citations

Thrombosis, Cardiovascular Disease, Paroxysmal Atrial Fibrillation +9